Posting of an updated investor presentation

Posting of an updated investor presentation

London, 9 January 2015 - Sinclair IS Pharma plc (AIM:SPH.L) ("the Company"), the international specialty pharmaceutical company, announces that, ahead of JPMorgan's 33rd Healthcare Conference in San Francisco, its updated investor presentation is now available on the Company's website at www.sinclairispharma.com. 

Enquiries:

Sinclair IS Pharma plc Tel: +44 (0) 20 7467 6920

Chris Spooner, Chief Executive Officer

Financial Adviser

Rothschild Tel: +44 (0) 20 7280 5000

Dominic Hollamby

Julian Hudson

NOMAD and broker

Peel Hunt LLP Tel: +44 (0) 20 7418 8900

James Steel

Clare Terlouw

Notes for editors:

About Sinclair IS Pharma plc - see www.sinclairispharma.com

Sinclair IS Pharma is an international specialty pharmaceutical company centred on Dermatology, in particular Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on the Emerging Markets through long term multi-product, multi-country, sales, marketing and distribution deals with key strategic partners.